FDA announces firm distributing Chinese-made plastic syringes in the U.S. initiates recall

The Food and Drug Administration May 23 announced that Medline Industries, a firm marketing and distributing Chinese-manufactured plastic syringes within the U.S., initiated a recall to stop using affected products, including unauthorized plastic syringes made in China. On Tuesday, Chinese manufacturer Jiangsu Shenli Medical Production Co. initiated a recall to stop using its unauthorized syringes. The FDA last week recommended users immediately transition away from plastic syringes made by Jiangsu Shenli Medical Production Co., along with those made by Jiangsu Caina Medical Co., Zhejiang Longde Pharmaceutical Co. and Shanghai Kindly Enterprise Development Group Co.
Related News Articles
Headline
The Food and Drug Administration March 5 announced that Baxter Healthcare Corporation recalled its Spectrum infusion pumps due to the potential for missing…
Headline
The Food and Drug Administration Feb. 18 announced that ICU Medical is voluntarily recalling certain lots of its potassium chloride injection bags with…
Headline
The Trump administration yesterday announced it issued executive orders authorizing 25% tariffs on all steel and aluminum imports. Importantly, both steel and…
Headline
The Food and Drug Administration Dec. 31 released an alert highlighting a Baxter letter that recommended health care providers not use certain lots of Solution…
Headline
The Food and Drug Administration yesterday announced an import alert for plastic syringes manufactured by two China-based manufacturers, in addition to…
Headline
The Food and Drug Administration May 9 released final guidance clarifying the definition of “remanufacturing” for reusable medical devices needing…